You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Characteristics of in-depth interview study participants, N = 85

From: Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial

  ProBE/ProtecT participants N = 38 ProtecT participants N = 47 All participants
  No infection (N = 33, A1-A33) Infection (i) (N = 5, A34i-A38i) (N = 47, B39—B85) (N = 85)
Age at time of first biopsy: mean (SD) 64.3 (4.9) 60.8 (4.9) 63.5 (4.5) 63.6 (4.7)
Employment status N (%)
Full time 14 5 24 43
Not working 18 0 20 38
Part time 0 0 0 0
Not specified/missing 1 0 3 4
Ethnicity, N (%)
White 33 5 46 84
Other 0 0 1 1
Centre, N (%)
1 3 0 0 3
2 1 0 9 10
3 16 3 30 49
4 2 0 8 10
5 4 0 0 4
6 3 1 0 4
7 2 1 0 3
8 2 0 0 2
Initial PSA result ng/ml, median (Interquartile range) 6.0 (3.7 to 13.0) 4 (3.4 to 4.7) 4.3 (3.5 to 6.7) 4.5 (3.5 to 7.2)
Biopsy result    (Final biopsy)  
Benign 12 1 0 13
Localized cancer 12 4 47 63
Advanced cancer 9 0 0 9
Number of biopsies at time of interview
1 33 5 35 73
2 0 0 10 10
3 0 0 2 2
Interview type
Telephone 18 5 0 23
Face to face 15 0 47 62
Timing of interview N weeks post-biopsy Median (range) mean 10 (3–138) 33 18 (10–72) 35 41 (9–75)* 41 40 (3–138) 39
Treatment of infection
Hospital admission n/a 3 n/a 3
Family physician n/a 2 1** 3
Cancer treatment     
Radical prostatectomy - 17 17
Radical radiotherapy - - 15 15
Active monitoring - - 15 15
Other - - 0 0
  1. *calculated from date of most recent biopsy if more than one biopsy took place**1 man was prescribed antibiotics having consulted his family physician about post-biopsy bleeding; there was no evidence that this man actually experienced an infection.